Adherence Improvement and Measurement- AIM- System. Challenge Topic 10-MH-101
Adherence Improvement and Measurement- AIM- System. Challenge Topic 10-MH-101
批准号:
7815262
负责人:
JAMES S KAHN
金额:
$49.94万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-30 至 2011-08-31
关键词:
AIDS/HIV problemAddressAdherenceAnti-HIV AgentsAnti-Retroviral AgentsAreaBiological MarkersCaringCellular PhoneChronic DiseaseClinicalComplexCounselingDataDevelopmentDiabetes MellitusDiseaseDisease ProgressionDrug ExposureEducationEmployeeEmploymentEventFeedbackGoldHIVHIV InfectionsHairHealthHealthcareHypertensionIndiumInformation SystemsInformation TechnologyInterventionIntervention TrialMeasurementMeasuresMedicalMental HealthMental disordersMethodsModelingMonitorOutcomePatient CarePatient Self-ReportPatientsPersonal Health RecordsPersonsPharmaceutical PreparationsPharmacistsPrimary Health CareProcessProviderPublic HealthRandomized Clinical TrialsRandomized Controlled TrialsRegistriesReminder SystemsResearchResourcesRoleSamplingSan FranciscoSelf ManagementServicesSourceSurveysSystemTechnologyTimeToxic effectTreatment EfficacyTreatment ProtocolsTrustUnited States Agency for Healthcare Research and QualityUpper armViral Load resultWireless TechnologyWorkbasechronic care modelcommon treatmentdepressionfirewallhealth information technologyhypercholesterolemiaimprovedmedication compliancemortalitynovelpillpublic health relevanceresponsesafety nettreatment adherence
中文摘要
描述(由申请人提供):本申请涉及广泛的挑战领域(10)用于处理研究和特定挑战主题的保健数据的信息技术,10-MH-101:提高精神障碍和艾滋病毒/艾滋病治疗依从性的技术在安全网环境中接受护理的人,患有复杂疾病和慢性病的人往往有重大的健康负担,包括复杂的治疗方案,有限的获得保健信息的机会,以及支持其护理的保健信息技术不足。因此,应用慢性护理模式(CCM)可以改善对这些患者的护理,应用该模式可能提供重要的新的研究机会。临床信息系统(CIS)是CCM中的关键要素,具有三个重要作用:提醒系统、反馈机制和登记。虽然CIS将重点放在作为数据接收者的提供者上,但我们认为CIS可能同样重要地向患者(信息和医疗保健的消费者)提供数据。个人健康记录(PHR)是最近出现的一种日益普遍的应用,它充当患者的CIS。患者可以使用PHR来接收和理解信息,并回答研究问题,本质上是自我管理自己的健康。依从性对于患者获得抗逆转录病毒药物的最大益处至关重要,但依从性干预试验必须依赖良好的依从性衡量标准来评估干预的效果。用于评估依从性的典型措施,包括自我报告、药片计数和用药事件监测系统,都是有限的,一个独立的药物依从性“生物标记物”将是有用的。评估药物暴露没有黄金标准,甚至没有最佳方法;然而,我们的小组最近表明,病毒学反应的最强独立预测因子是锚定抗逆转录病毒药物的头发浓度。头发浓度比自我报告的依从性更能预测疗效。在这个项目中,我们将直接在安全网环境中与服务不足的患者合作,进行一项随机临床试验,比较护理标准依从性咨询与嵌入现有PHR中的一种新型依从性干预,该干预使用手机短信服务(SMS)提醒和患者对提醒的响应。我们将通过头发样本中的抗逆转录病毒药物浓度和自我报告来比较两组患者的依从率;临床结果也将在两组患者中进行比较。该项目将检查抗逆转录病毒药物以及抑郁症、高血压、糖尿病和高胆固醇血症等常见疾病的治疗依从性。我们的假设是,从受信任的个人健康记录(自我管理干预)收到私人和个性化的药物依从性提醒的人将提高依从率,有助于更好的临床结果。
公共卫生相关性:安全网环境中的人,特别是艾滋病毒感染者的初级保健依赖于复杂的信息来源。现在有五类药物中的31种获得批准的抗艾滋病毒药物,这些药物大大降低了死亡率和疾病进展,但有显著的毒性。我们的项目将开发一款应用程序,利用无线技术促进服药依从性。具体地说,该项目将检查抗逆转录病毒药物以及常见的医疗和心理健康状况,如抑郁症、高血压、糖尿病和高胆固醇血症的用药依从性。
英文摘要
DESCRIPTION (provided by applicant): This application addresses broad Challenge Area (10) Information Technology for Processing Health Care Data for Research and specific Challenge Topic, 10-MH-101: Technologies to improve treatment adherence for mental disorders and HIV/AIDS Persons receiving care in safety-net settings, with complex diseases and chronic conditions often have significant health burdens including complicated treatment regimens, limited access to health information and inadequate health information technology to support their care. Thus, applying the chronic care model (CCM) may improve the care for these patients and applying this model may offer important new research opportunities. Clinical information systems (CIS) are a key element in the CCM and have three important roles: reminder systems; feedback mechanisms; and registries. While CIS have focused on the provider as the recipient of data, we believe that a CIS might just as importantly provide data to patients (the consumers of information and healthcare). The personal health record (PHR) is a recent, increasingly common application acting as a CIS for patients. Patients can use PHRs to receive and understand information and respond to research questions, in essence self-managing their health. Adherence is critically important for patients to achieve the maximal benefits of antiretroviral medications, but an adherence intervention trial must rely on good measures of adherence to assess the efficacy of the intervention. Typical measures used to assess adherence, including self-report, pill counts and medication event monitoring systems, are limited, and a independent "biomarker" of drug adherence would be useful. There is no gold standard or even optimal method for the assessment of drug exposure; however, our group has recently shown that the strongest independent predictor for virologic response is hair concentrations of the anchor antiretroviral medication. Hair concentrations were stronger predictors of response than self-reported adherence. In this project, we will work directly with underserved patients in a safety-net setting to conduct a randomized clinical trial of standard-of-care adherence counseling versus a novel adherence intervention embedded in an existing PHR that uses cellular phone short message service (SMS) reminders and patient responses to the reminders. We will compare adherence rates in both arms as assessed by antiretroviral medication concentrations in hair samples and self-report; clinical outcomes will also be compared in the two arms. The project will examine medication adherence for antiretroviral medications and treatments of common conditions such as depression, hypertension, diabetes and hypercholesterolemia. Our hypotheses are that persons receiving private and individualized automated reminders for medication adherence from trusted personal health records (the self-management intervention) will have improved rates of adherence, contributing to better clinical outcomes.
PUBLIC HEALTH RELEVANCE: Primary care for persons in the safety net setting and specifically for persons with HIV infection relies on complex sources of information. There are now thirty-one approved anti-HIV agents from five classes of medications, and these medications substantially reduce mortality and disease progression but have significant toxicities. Our project will develop an application to promote medication adherence using wireless technology. Specifically the project will examine the medication adherence for antiretroviral medications and common medical and mental health conditions such as depression, hypertension, diabetes and hypercholesterolemia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Seek, Test, Treat and Retain strategies leveraging mobile health technologies
-
批准号:8189772
-
项目类别:
-
资助金额:$55.87万
-
财政年份:2011
-
负责人:JAMES S KAHN
-
依托单位:
Adherence Improvement and Measurement- AIM- System. Challenge Topic 10-MH-101
-
批准号:7937944
-
项目类别:
-
资助金额:$49.87万
-
财政年份:2009
-
负责人:JAMES S KAHN
-
依托单位:
Randomized controlled trial embedded in an electronic health record
-
批准号:7942774
-
项目类别:
-
资助金额:$40.06万
-
财政年份:2008
-
负责人:JAMES S KAHN
-
依托单位:
Randomized controlled trial embedded in an electronic health record
-
批准号:7680092
-
项目类别:
-
资助金额:$39.3万
-
财政年份:2008
-
负责人:JAMES S KAHN
-
依托单位:
Randomized controlled trial embedded in an electronic health record
-
批准号:7575066
-
项目类别:
-
资助金额:$40.64万
-
财政年份:2008
-
负责人:JAMES S KAHN
-
依托单位:
Integrating HIV Resistance Data into the CNICS Cohort
-
批准号:7058411
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2004
-
负责人:JAMES S KAHN
-
依托单位:
Observational Cohort of HIV-Infected Persons
-
批准号:6539323
-
项目类别:
-
资助金额:$11.2万
-
财政年份:2001
-
负责人:JAMES S KAHN
-
依托单位:
Mentoring HIV and Translational Scientists and Developing an EMR Based Research
-
批准号:7502692
-
项目类别:
-
资助金额:$10.85万
-
财政年份:2001
-
负责人:JAMES S KAHN
-
依托单位:
Observational Cohort of HIV-Infected Persons
-
批准号:6646503
-
项目类别:
-
资助金额:$11.45万
-
财政年份:2001
-
负责人:JAMES S KAHN
-
依托单位:
Mentoring HIV and Translational Scientists and Developing an EMR Based Research
-
批准号:7418779
-
项目类别:
-
资助金额:$10.79万
-
财政年份:2001
-
负责人:JAMES S KAHN
-
依托单位:
Observational Cohort of HIV-Infected Persons
-
批准号:6763981
-
项目类别:
-
资助金额:$11.72万
-
财政年份:2001
-
负责人:JAMES S KAHN
-
依托单位:
Mentoring HIV and Translational Scientists and Developing an EMR Based Research
-
批准号:7632051
-
项目类别:
-
资助金额:$11.12万
-
财政年份:2001
-
负责人:JAMES S KAHN
-
依托单位:
Observational Cohort of HIV-Infected Persons
-
批准号:6408003
-
项目类别:
-
资助金额:$10.93万
-
财政年份:2001
-
负责人:JAMES S KAHN
-
依托单位:
Mentoring HIV and Translational Scientists and Developing an EMR Based Research
-
批准号:8069835
-
项目类别:
-
资助金额:$11.33万
-
财政年份:2001
-
负责人:JAMES S KAHN
-
依托单位:
Observational Cohort of HIV-Infected Persons
-
批准号:6899711
-
项目类别:
-
资助金额:$11.99万
-
财政年份:2001
-
负责人:JAMES S KAHN
-
依托单位:
SAFETY, TOLERABILITY, AND ANTIRETROVIRAL ACTIVITY OF DMP 266
-
批准号:6115459
-
项目类别:
-
资助金额:$3.1万
-
财政年份:1998
-
负责人:JAMES S KAHN
-
依托单位:
SAFETY, TOLERANCE, PK ANTIVIRAL ACTIVITY OF FTC IN PATIENTS WITH HIV
-
批准号:6219488
-
项目类别:
-
资助金额:$0.06万
-
财政年份:1998
-
负责人:JAMES S KAHN
-
依托单位:
SAFETY, TOLERANCE, PK ANTIVIRAL ACTIVITY OF FTC IN PATIENTS WITH HIV
-
批准号:6115501
-
项目类别:
-
资助金额:$3.1万
-
财政年份:1998
-
负责人:JAMES S KAHN
-
依托单位:
SAFETY, TOLERABILITY, AND ANTIRETROVIRAL ACTIVITY OF DMP 266
-
批准号:6246613
-
项目类别:
-
资助金额:$3.14万
-
财政年份:1997
-
负责人:JAMES S KAHN
-
依托单位:
SAFETY AND PHARMACOKINETIC PROFILE FOLLOWING SINGLE DOSES OF AR 177 IN HIV
-
批准号:6246598
-
项目类别:
-
资助金额:$3.14万
-
财政年份:1997
-
负责人:JAMES S KAHN
-
依托单位:
海外基金